Wednesday, 20 Mar 2019

You are here

The RheumNow Week in Review – 6 May 2016

Highlights from this week on include:

  1. Registry study (ARTIS & DANBIO) of Spondyloarthritis & Psoriatic arthritis patients show NO cancer risk associated with SpA or PsA; moreover TNF inhibitor use does not augment the cancer risk in these patients. 
  2. May is lupus awareness month. 
  3. CARDERA-2 clinical trial of 154 early RA pts showed that Anakinra+MTX was not better than MTX alone- in early RA - both Xray & clinical outcomes. Questions the value of anakinra in RA.  
  4. Health Canada approves secukinumab for use in psoriatic arthritis and anklylosing spondylitis 
  5. Acute scrotal swelling in Henoch Schonlein purpura occurs in 10-30% of boys, 60% are unilateral.  Treatment with steroids? 
  6. Late onset SLE (>50yrs) patients have less cutaneous disease (malar rash, photosensitivity, livedo) but more Sicca Sx 
  7. Metanalysis: TNF inhibitors are shown to be associated with an increase risk of perioperative infections (SSI): BUT the infection risk decreases >38% with temporary cessation of TNFi before surgery. 
  8. Dr. Nicola Dalbeths #Gout review in Lancet is stellar! She's leading the field w/ DECT scans, research & smart Rx. 
  9. RheumNow posts a free download – Patient Guide to Biologics  
  10. FDA REMS/Safety Panel Backs Educational Requirements for Opioid Prescribers 
  11. Simple Referral Rule May Lead to Earlier Referral and Diagnosis of Axial Spondyloarthritis. Rule: needs to 2 of 4 to refer suspected SpA – 1) inflammatory low back pain; 2) back pain > 5 yrs.; 3) good response to NSAIDs; and 4) family history of spondyloarthritis. 
  12. CDC Updates Arthritis Numbers – 25% of US adults have arthritis. 
  13. Poor Outcomes for Dermato/Polymyositis Admitted to ICU. 
  14. Can Rituximab Change the Course of Interstitial Lung Disease.  
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

RheumNow Podcast – You Owe Me a DEXA (3.15.19)

Dr. Jack Cush reviews this week's news and highlights from

RheumNow Podcast – Delays in Diagnosis (3.8.19)

Dr. Jack Cush reviews the news and journal reports from the past week on

Medical Meetings: Should I Stay or Should I Go?

Say a conference in your field was just announced. You think you "should" go, and you know you'll be choosing from many presentation opportunities that feature the latest research — which you want to know about. And you'll get to hang with like minds and talk about things that matter.

RheumNow Podcast – Scleroderma and the Lung (3.1.19)

Dr. Jack Cush Reviews the news and journal articles from the past week on

RheumNow Podcast - Death and Surgery (2-22-19)

Dr. Jack Cush reviews the news and journal reports from the past week on